Trial intelligence / Profile preview

Triamcinolone vs Laser for Diabetic Macular Edema

NCT00105404Phase 3Completed

Sponsor
National Eye Institute
Start
Mar 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of triamcinolone acetonide in diabetic macular edema (DME), sponsored by National Eye Institute. Started Mar 2005; status: completed.

02

Drugs

triamcinolone acetonide
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on NCT00105404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00105404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call